DE602005017815D1 - Behandlung von entzündlicher darmerkrankung - Google Patents

Behandlung von entzündlicher darmerkrankung

Info

Publication number
DE602005017815D1
DE602005017815D1 DE602005017815T DE602005017815T DE602005017815D1 DE 602005017815 D1 DE602005017815 D1 DE 602005017815D1 DE 602005017815 T DE602005017815 T DE 602005017815T DE 602005017815 T DE602005017815 T DE 602005017815T DE 602005017815 D1 DE602005017815 D1 DE 602005017815D1
Authority
DE
Germany
Prior art keywords
endurance
inflammatory
treatment
animal
analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005017815T
Other languages
English (en)
Inventor
David W Old
Danny T Dinh
Karen M Kedzie
Daniel W Gil
Wha Bin Im
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of DE602005017815D1 publication Critical patent/DE602005017815D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C07D211/76—Oxygen atoms attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005017815T 2004-11-29 2005-11-22 Behandlung von entzündlicher darmerkrankung Active DE602005017815D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/999,451 US7326716B2 (en) 2003-06-06 2004-11-29 Treatment of inflammatory bowel disease
PCT/US2005/042467 WO2006058080A1 (en) 2004-11-29 2005-11-22 Treatment of inflammatory bowel disease

Publications (1)

Publication Number Publication Date
DE602005017815D1 true DE602005017815D1 (de) 2009-12-31

Family

ID=35903405

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005017815T Active DE602005017815D1 (de) 2004-11-29 2005-11-22 Behandlung von entzündlicher darmerkrankung

Country Status (10)

Country Link
US (1) US7326716B2 (de)
EP (1) EP1817033B1 (de)
AT (1) ATE448785T1 (de)
AU (1) AU2005309622A1 (de)
BR (1) BRPI0518690A2 (de)
CA (1) CA2589438C (de)
DE (1) DE602005017815D1 (de)
DK (1) DK1817033T3 (de)
ES (1) ES2334374T3 (de)
WO (1) WO2006058080A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7700627B2 (en) * 2006-07-26 2010-04-20 Allergan, Inc. Therapeutic substituted lactams
SI2289518T1 (sl) * 2008-06-23 2017-02-28 Nippon Shinyaku Co., Ltd. Terapevtsko sredstvo za vnetno črevesno bolezen
EP2198879A1 (de) 2008-12-11 2010-06-23 Institut Curie CD74-modulierender Wirkstoff zur Regulierung der Dendritenzellmigration und Verfahren zur Untersuchung der Bewegungsfähigkeit einer Zelle
EP2199273B1 (de) 2008-12-18 2018-02-21 Agfa Nv Polymerisierbare Fotoinitiatoren und strahlungshärtbare Zusammensetzungen
US8883873B2 (en) 2009-05-18 2014-11-11 Agfa Graphics Nv Polymerizable polymeric photoinitiators and radiation curable compositions
NZ599128A (en) 2009-10-14 2014-02-28 Gemmus Pharma Inc Combination therapy treatment for viral infections
EP2447259B1 (de) 2010-10-20 2016-03-16 Agfa Graphics N.V. Polymerisierbare Fotoinitiatoren für LED-härtbare Zusammensetzungen
US20140142042A1 (en) * 2012-11-16 2014-05-22 Allergan, Inc. Skin wound healing and scar reduction with prostaglandin ep4 agonist combinations
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
EP2868650B1 (de) 2013-10-30 2018-08-08 Agfa Nv Synthese von Acetalverbindungen unter Verwendung von zwitterionischen Katalysatoren
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994274A (en) * 1989-07-27 1991-02-19 Allergan, Inc. Intraocular pressure reducing 11,15-diacyl prostaglandins and method of using
CA2021316C (en) * 1989-07-27 2000-10-24 Ming Fai Chan Intraocular pressure reducing 11-acyl prostaglandins
US5034413A (en) * 1989-07-27 1991-07-23 Allergan, Inc. Intraocular pressure reducing 9,11-diacyl prostaglandins
US5028624A (en) * 1989-07-27 1991-07-02 Allergan, Inc. Intraocular pressure reducing 9,15-diacyl prostaglandins
SE520947C2 (sv) * 2002-01-18 2003-09-16 Aneo Ab Ventilarrangemang för blandning av två medier
AU2003278987A1 (en) * 2002-09-26 2004-04-19 The Children's Hospital Of Philadelphia Method of determining surface binding capacity
US7053085B2 (en) 2003-03-26 2006-05-30 Merck & Co. Inc. EP4 receptor agonist, compositions and methods thereof
JP2006515015A (ja) * 2003-01-10 2006-05-18 エフ．ホフマン−ラ　ロシュ　アーゲー プロスタグランジンアゴニストとしての２−ピペリドン誘導体
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US6977260B2 (en) * 2004-01-22 2005-12-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US6747037B1 (en) * 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
DE10341727A1 (de) * 2003-09-10 2005-04-28 Starck H C Gmbh Reinigung von Ammoniummetallat-Lösungen
EP1761495B1 (de) 2004-06-04 2012-03-21 Allergan, Inc. Piperidinyl-prostaglandinanaloga als den augeninnendruck senkende mittel

Also Published As

Publication number Publication date
DK1817033T3 (da) 2010-03-08
EP1817033A1 (de) 2007-08-15
CA2589438A1 (en) 2006-06-01
BRPI0518690A2 (pt) 2008-12-02
AU2005309622A1 (en) 2006-06-01
US7326716B2 (en) 2008-02-05
ATE448785T1 (de) 2009-12-15
US20050171062A1 (en) 2005-08-04
EP1817033B1 (de) 2009-11-18
WO2006058080A1 (en) 2006-06-01
ES2334374T3 (es) 2010-03-09
CA2589438C (en) 2014-07-22

Similar Documents

Publication Publication Date Title
DE602005017815D1 (de) Behandlung von entzündlicher darmerkrankung
EA200601239A1 (ru) Замещённые хинолиновые соединения
NO20084502L (no) Tetrahydropyrrolopyrimidinedioner og deres anvendelse som humane neutrofil elastase inhibitorer
ATE440087T1 (de) 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
MA28935B1 (fr) Preparation et utilisation de derives de biphenyl-4-yl-carbonylamino-acide dans le traitement de l'obesite
ATE544748T1 (de) Zusammensetzungen und verfahren für die behandlung von zellproliferationserkrankungen
ATE519488T1 (de) Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten
ATE445415T1 (de) Verwendung von il-23 und il-17-antagonisten zur behandlung von autoimmuner entzündlicher augenerkrankung
ATE478864T1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
EA200601841A1 (ru) Композиции, содержащие ингибитор jnk и циклоспорин
MA31086B1 (fr) Formulations de doses unitaires et procedes de traitement d'une thrombose avec un inhibiteur oral du facteur xa.
CY1107956T1 (el) Χρηση υποκατεστημενων 2-αμινοτετραλινιων για την προληπτικη αντιμετωπιση της νοσου του παρκινσον
EA200801842A1 (ru) Антитела против бета-амилоидного пептида
ECSP066684A (es) Nitrooxiderivados de prostaglandinas
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
EA200870019A1 (ru) Лактамовые соединения и способы их применения
EA200601895A1 (ru) 3-(4-гетероарилциклогексиламино)циклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
ATE446102T1 (de) Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii
DE60219614D1 (de) 3, 7 thiaprostansäurederivate als mittel zur verminderung des augeninnendruckes
DE602005013085D1 (de) Proteinkinaseinhibitoren
EA200801244A1 (ru) Применение sdf-1 для лечения и/или профилактики неврологических заболеваний
EA200601607A1 (ru) Сульфонамидные соединения для лечения нейродегенеративных расстройств
ATE491453T1 (de) Verwendung von 4-aminochinolin-verbindungen zur behandlung entzündlicher erkrankungen des auges
DE602004023721D1 (de) Zusammensetzungen und methoden für die behandlung von herzerkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition